Citation: | LIU Lu, LIU Xiao-yu. Role of general practitioners in the integrated management of atrial fibrillation[J]. Chinese Journal of General Practice, 2021, 19(9): 1553-1556. doi: 10.16766/j.cnki.issn.1674-4152.002110 |
[1] |
DAI H, ZHANG Q, MUCH A A, et al. Global, regional, and national prevalence, incidence, mortality, and risk factors for atrial fibrillation, 1990-2017: Results from the Global Burden of Disease Study 2017[J]. Eur Heart J Qual Care Clin Outcomes, 2020. DOI: 10.1093/ehjqcco/qcaa061.
|
[2] |
WANG Z, CHEN Z, WANG X, et al. The disease burden of atrial fibrillation in China from a national cross-sectional survey[J]. Am J Cardiol, 2018, 122(5): 793-798. doi: 10.1016/j.amjcard.2018.05.015
|
[3] |
JOSEPH P G, HEALEY J S, RAINA P, et al. Global variations in the prevalence, treatment, and impact of atrial fibrillation in a multi-national cohort of 153, 152 middle-aged individuals[J]. Cardiovasc Res, 2020. DOI:10.1093/cvr/cvaa 241.
|
[4] |
WANG X, FU Q, SONG F, et al. Prevalence of atrial fibrillation in different socioeconomic regions of China and its association with stroke: Results from a national stroke screening survey[J]. Int J Cardiol, 2018, 271: 92-97. doi: 10.1016/j.ijcard.2018.05.131
|
[5] |
LI Y G, LIP G Y H. Stroke prevention in atrial fibrillation: State of the art [J]. Int J Cardiol, 2019, 287: 201-209. doi: 10.1016/j.ijcard.2018.09.057
|
[6] |
RUDDOX V, SANDVEN I, MUNKHAUGEN J, et al. Atrial fibrillation and the risk for myocardial infarction, all-cause mortality and heart failure: A systematic review and meta-analysis[J]. Eur J Prev Cardiol, 2017, 24(14): 1555-1566. doi: 10.1177/2047487317715769
|
[7] |
STAERK L, SHERER J A, Ko D, et al. Atrial fibrillation: Epidemiology, pathophysiology, and clinical outcomes[J]. Circ Res, 2017, 120(9): 1501-1517. doi: 10.1161/CIRCRESAHA.117.309732
|
[8] |
CHUGH S S, HAVMOELLER R, NARAYANAN K, et al. Worldwide epidemiology of atrial fibrillation: A global burden of disease 2010 study[J]. Circulation, 2014, 129(8): 837-847. doi: 10.1161/CIRCULATIONAHA.113.005119
|
[9] |
JANUARY C T, WANN L S, CALKINS H, et al. 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS Guideline for the management of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association task force on clinical practice Guidelines and the Heart Rhythm Society in collaboration with the Society of Thoracic Surgeons [J]. Circulation, 2019, 140(2): e125-e151. http://www.sciencedirect.com/science/article/pii/S1547527119300372
|
[10] |
黄从新, 张澍, 黄德嘉, 等. 心房颤动: 目前的认识和治疗建议(2018)[J]. 中华心律失常学杂志, 2018, 22(4): 279-346. doi: 10.3760/cma.j.issn.1007-6638.2018.04.002
|
[11] |
HINDRICKS G, POTPARA T, DAGRES N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS)[J]. Eur Heart J, 2020, 42(5): 373-498. http://d.wanfangdata.com.cn/periodical/7b60f7723a742343d756f8a32ff23250
|
[12] |
POKORNEY S D, PICCINI J P, STEVENS S R, et al. Cause of death and predictors of all-cause mortality in anticoagulated patients with nonvalvular atrial fibrillation: Data from ROCKET AF[J]. J Am Heart Assoc, 2016, 5(3): e002197. http://dash.harvard.edu/bitstream/handle/1/27822378/4943233.pdf?sequence=1
|
[13] |
HENDRIKS J M L, TIELEMAN R G, VRIJHOEF H J M, et al. Integrated specialized atrial fibrillation clinics reduce all-cause mortality: Post hoc analysis of a randomized clinical trial[J]. Europace, 2019, 21(12): 1785-1792. doi: 10.1093/europace/euz209
|
[14] |
GALLAGHER C, ELLIOTT A D, WONG C X, et al. Integrated care in atrial fibrillation: A systematic review and meta-analysis[J]. Heart, 2017, 103(24): 1947-1953. http://heart.bmj.com/content/103/24/1947.full.pdf
|
[15] |
PROIETTI M, ROMITI G F, OLSHANSKY B, et al. Improved outcomes by integrated care of anticoagulated patients with atrial fibrillation using the simple ABC (Atrial Fibrillation Better Care) pathway[J]. Am J Med, 2018, 131(11): 1359-1366. doi: 10.1016/j.amjmed.2018.06.012
|
[16] |
KIRCHHOF P, BENUSSI S, KOTECHA D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS[J]. Europace, 2016, 18(11): 1609-1678. doi: 10.1093/europace/euw295
|
[17] |
GORENEK B, PELLICCIA A, BENJAMIN E J, et al. European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS)[J]. Eur J Prev Cardiol, 2017, 24(1): 4-40. doi: 10.1177/2047487316676037
|
[18] |
SHARASHOVA E, WILSGAARD T, BALL J, et al. Long-term blood pressure trajectories and incident atrial fibrillation in women and men: The TromsØ Study [J]. Eur Heart J, 2020, 41(16): 1554-1562. doi: 10.1093/eurheartj/ehz234
|
[19] |
SOLIMAN E Z, RAHMAN A F, ZHANG Z M, et al. Effect of intensive blood pressure lowering on the risk of atrial fibrillation[J]. Hypertension, 2020, 75(6): 1491-1496. doi: 10.1161/HYPERTENSIONAHA.120.14766
|
[20] |
AUNE D, FENG T, SCHLESINGER S, et al. Diabetes mellitus, blood glucose and the risk of atrial fibrillation: A systematic review and meta-analysis of cohort studies[J]. J Diabetes Complications, 2018, 32(5): 501-511. doi: 10.1016/j.jdiacomp.2018.02.004
|
[21] |
SEYED A S, SVENSSON A M, PIVODIC A, et al. Risk of atrial fibrillation in persons with type 2 diabetes and the excess risk in relation to glycaemic control and renal function: A swedish cohort study[J]. Cardiovasc Diabetol, 2020, 19(1): 9. doi: 10.1186/s12933-019-0983-1
|
[22] |
YANG S, CHOI E K, HAN K D, et al. Risk of atrial fibrillation in relation to the time course of type 2 diabetes mellitus and fasting blood glucose[J]. Am J Cardiol, 2019, 124(12): 1881-1888. doi: 10.1016/j.amjcard.2019.09.009
|
[23] |
LAVIE C J, PANDEY A, LAU D H, et al. Obesity and atrial fibrillation prevalence, pathogenesis, and prognosis: Effects of weight loss and exercise[J]. J Am Coll Cardiol, 2017, 70(16): 2022-2035. doi: 10.1016/j.jacc.2017.09.002
|
[24] |
KENDZERSKA T, GERSHON A S, ATZEMA C, et al. Sleep apnea increases the risk of new hospitalized atrial fibrillation: A historical cohort study[J]. Chest, 2018, 154(6): 1330-1339. doi: 10.1016/j.chest.2018.08.1075
|
[25] |
JOHANSSON C, LIND M M, ERIKSSON MARIE, et al. Alcohol consumption and risk of incident atrial fibrillation: A population-based cohort study[J]. Eur J Intern Med, 2020, 76: 50-57. doi: 10.1016/j.ejim.2020.02.022
|
[26] |
MIDDELDORP M E, ARIYARATNAM J, LAU D, et al. Lifestyle modifications for treatment of atrial fibrillation[J]. Heart, 2020, 106(5): 325-332. doi: 10.1136/heartjnl-2019-315327
|
[27] |
JIANG C, LAN D, DU X, et al. Prevalence of modifiable risk factors and relation to stroke and death in patients with atrial fibrillation: A report from the China atrial fibrillation registry study [J]. J Cardiovasc Electrophysiol, 2019, 30(12): 2759-2766. doi: 10.1111/jce.14231
|
[28] |
吴书林. 重视心房颤动的上游治疗[J]. 中华心血管病杂志, 2020, 48(12): 993-994. doi: 10.3760/cma.j.cn112148-20201102-00875
|
[29] |
刘松涛, 罗潇, 李萍. 心房颤动上游治疗的研究进展[J]. 中华全科医学, 2018, 16(11): 1886-1889. https://www.cnki.com.cn/Article/CJFDTOTAL-SYQY201811035.htm
|
[30] |
刘彤, 陈子良. 生活方式改变上游药物治疗对心房颤动的预防和治疗证据[J]. 中国实用内科杂志, 2020, 40(3): 182-186. https://www.cnki.com.cn/Article/CJFDTOTAL-SYNK202003003.htm
|
[31] |
国家卫生健康委办公厅, 国家中医药管理局办公室. 《关于印发心房颤动分级诊疗服务技术方案的通知》(国卫办医函[2019]710号)[EB/OL]. (2019-09-05)[2020-09-21]. http://www.nhc.gov.cn/yzygj/s3594q/201909/592e8b8ac8044617bc9ed9186c2ee19f.shtml.
|
[32] |
中华医学会, 中华医学会杂志社, 中华医学会全科医学分会, 等. 心房颤动基层诊疗指南(2019年)[J]. 中华全科医师杂志, 2020, 19(6): 465-473. doi: 10.3760/cma.j.cn114798-20191118-00838
|
[33] |
基层心血管病综合管理实践指南2020[J]. 中国医学前沿杂志(电子版), 2020, 12(8): 1-73.
|
[34] |
MAIRESSE G H, MORAN P, VAN GELDER I C, et al. Screening for atrial fibrillation: A European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLAECE) [J]. Europace, 2017, 19(10): 1589-1623. doi: 10.1093/europace/eux177
|
[35] |
PEREZ M V, MAHAFFEY K W, HEDLIN H, et al. Large-Scale assessment of a smartwatch to identify atrial fibrillation[J]. N Engl J Med, 2019, 381(20): 1909-1917. doi: 10.1056/NEJMoa1901183
|
[36] |
白重阳, 张惠中. 华法林对房颤患者的凝血功能血小板参数以及血流变化的影响[J]. 河北医学, 2020, 26(1): 173-176. doi: 10.3969/j.issn.1006-6233.2020.01.042
|
[37] |
倪岚, 薛锦花, 薛峰. 上海市浦东新区全科医生心房颤动认识的现状调查[J]. 中华全科医师杂志, 2018, 17(11): 895-900. doi: 10.3760/cma.j.issn.1671-7368.2018.11.008
|
[38] |
BAI Y, WANG Y L, SHANTSILA A, et al. The global burden of atrial fibrillation and stroke: A systematic review of the clinical epidemiology of atrial fibrillation in Asia [J]. Chest, 2017, 152(4): 810-820. doi: 10.1016/j.chest.2017.03.048
|
[39] |
国家心血管病医疗质量控制中心专家委员会心房颤动专家工作组. 2019年中国心房颤动医疗质量控制报告[J]. 中国循环杂志, 2020, 35(5): 427-437. doi: 10.3969/j.issn.1000-3614.2020.05.003
|
[40] |
张凤艳, 冯天元, 徐建, 等. 农村社区房颤患者综合管理效果评价[J]. 浙江临床医学, 2018, 20(10): 1678-1680.
|
[41] |
颜骅, 施建华, 周剑峰, 等. 社区脑卒中患者各级康复准入及准出标准建立研究[J]. 中国全科医学, 2019, 22(20): 2398-2405. doi: 10.12114/j.issn.1007-9572.2019.00.174
|
[42] |
LONG L, MORDI I R, BRIDGES C, et al. Exercise-based cardiac rehabilitation for adults with heart failure[J]. Cochrane Database Syst Rev, 2019, 1(1): CD003331. http://www.researchgate.net/publication/330733496_Exercise-based_cardiac_rehabilitation_for_adults_with_heart_failure
|
[43] |
JONES B, MCCLEAN S, STANFORD D. Modelling mortality and discharge of hospitalized stroke patients using a phase-type recovery model[J]. Health Care Manag Sci, 2019, 22(4): 570-588. doi: 10.1007/s10729-018-9446-6
|